Skip to Content

News Release

Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2021

November 4, 2021 at 7:30 AM EDT

BANNOCKBURN, Ill., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2021.

Third Quarter 2021 Financial Highlights

  • Net revenue of $891.9 million, up 14.1% compared to $781.6 million in the third quarter of 2020
  • Gross profit of $203.0 million, or 22.8% of net revenue, up 16.5% compared to $174.2 million, or 22.3% of revenue, in the third quarter of 2020
  • Net income of $35.5 million, or $0.20 per share, compared to net income of $1.7 million, or $0.01 per share, in the third quarter of 2020
  • Adjusted EBITDA of $78.0 million, up 31.7% compared to $59.2 million in the third quarter of 2020
  • Cash flow from operations of $51.2 million compared to a cash flow of $48.3 million in the third quarter of 2020
  • Cash balances of $200.9 million at the end of the third quarter

John C. Rademacher, Chief Executive Officer, commented, “The Option Care Health team continues to execute on our mission of delivering extraordinary patient care in a challenging environment. The third quarter results reflect the dedication of the entire team and our ability to generate profitable growth and significant cash flow. While navigating the current pandemic situation, we are investing for future growth, including the recently announced acquisition of Infinity Infusion Nursing.”

Full Year 2021 Guidance

For the full year 2021, Option Care Health is revising its financial guidance as follows:

  • Net Revenue of $3.35 billion to $3.50 billion (unchanged)
  • Adjusted EBITDA of $283 million to $288 million
  • Cash Flow from Operations of at least $180 million

Conference Call

The Company will host a conference call this morning at 8:30 a.m. E.T. which can be accessed by dialing (866) 360-3136 and referencing conference ID 2812558; or via a live audio webcast that will be available online at https://investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 5,000 teammates, including approximately 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates. To learn more, please visit our website at OptionCareHealth.com.

Investor Contacts

Mike Shapiro Bob East, Asher Dewhurst, Jordan Kohnstam
Chief Financial Officer Westwicke
T: (312) 940-2538 T: (413) 213-0500
mike.shapiro@optioncare.com optioncarehealth@westwicke.com

Forward-Looking Statements - Safe Harbor
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial conditions.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings; (iii) results of litigation; (iv) the loss of one or more key payers; and (v) the spread and impact of the COVID-19 pandemic. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Note Regarding Use of Non-GAAP Financial Measures

In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is not a measurement of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, operating income or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company’s liquidity. In addition, the Company's definition of Adjusted EBITDA may not be comparable to similarly titled non-GAAP financial measures reported by other companies. Adjusted EBITDA, as defined by the Company, represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, and restructuring, integration and other expenses. As part of restructuring, integration and other expenses, the Company may incur significant charges such as the write down of certain long−lived assets, temporary redundant expenses, professional fees, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that Adjusted EBITDA provides useful supplemental information regarding the performance of Option Care Health’s business operations and facilitates comparisons to the Company’s historical operating results. For a full reconciliation of Adjusted EBITDA to the most comparable GAAP financial measure, please see the attachment to this earnings release.



Schedule 1

OPTION CARE HEALTH, INC. 
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)

       
       
  (unaudited)    
  September 30,   December 31,
  2021   2020
ASSETS      
CURRENT ASSETS:      
Cash and cash equivalents $ 200,856     $ 99,265  
Accounts receivable, net 355,650     328,340  
Inventories 189,830     158,601  
Prepaid expenses and other current assets 64,848     70,806  
Total current assets 811,184     657,012  
       
NONCURRENT ASSETS:      
Property and equipment, net 106,788     121,149  
Intangible assets, net 343,764     351,052  
Goodwill 1,428,610     1,428,610  
Other noncurrent assets 95,798     89,616  
Total noncurrent assets 1,974,960     1,990,427  
TOTAL ASSETS $ 2,786,144     $ 2,647,439  
       
LIABILITIES AND STOCKHOLDERS’ EQUITY      
CURRENT LIABILITIES:      
Accounts payable $ 318,561     $ 282,913  
Other current liabilities 167,103     151,110  
Total current liabilities 485,664     434,023  
       
NONCURRENT LIABILITIES:      
Long-term debt, net of discount, deferred financing costs and current portion 1,117,823     1,115,103  
Other noncurrent liabilities 85,177     82,589  
Total noncurrent liabilities 1,203,000     1,197,692  
Total liabilities 1,688,664     1,631,715  
       
STOCKHOLDERS’ EQUITY 1,097,480     1,015,724  
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 2,786,144     $ 2,647,439  



Schedule 2

OPTION CARE HEALTH, INC. 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

       
       
  Three Months Ended
September 30,
  Nine Months Ended
September 30,
  2021   2020   2021   2020
NET REVENUE $ 891,937     $ 781,609     $ 2,511,446     $ 2,227,897  
COST OF REVENUE 688,969     607,456     1,944,037     1,729,395  
GROSS PROFIT 202,968     174,153     567,409     498,502  
               
OPERATING COSTS AND EXPENSES:              
Selling, general and administrative expenses 134,633     123,000     388,930     377,198  
Depreciation and amortization expense 15,452     16,597     48,410     54,892  
Total operating expenses 150,085     139,597     437,340     432,090  
OPERATING INCOME 52,883     34,556     130,069     66,412  
               
OTHER INCOME (EXPENSE):              
Interest expense, net (16,000 )   (24,583 )   (52,717 )   (84,102 )
Other, net 1,680     (7,554 )   (7,825 )   (5,958 )
Total other expense (14,320 )   (32,137 )   (60,542 )   (90,060 )
               
INCOME (LOSS) BEFORE INCOME TAXES 38,563     2,419     69,527     (23,648 )
               
INCOME TAX EXPENSE 3,087     756     5,096     2,267  
NET INCOME (LOSS) $ 35,476     $ 1,663     $ 64,431     $ (25,915 )
               
Earnings (loss) per share, basic and diluted $ 0.20     $ 0.01     $ 0.36     $ (0.14 )



Schedule 3

OPTION CARE HEALTH, INC. 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)

   
   
  Nine Months Ended
September 30,
  2021   2020
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income (loss) $ 64,431     $ (25,915 )
Adjustments to reconcile net income (loss) to net cash provided by operations:      
Depreciation and amortization expense 52,820     60,054  
Other non-cash adjustments 32,842     39,503  
Changes in operating assets and liabilities:      
Accounts receivable, net (27,310 )   3,496  
Inventories (31,472 )   (39,602 )
Accounts payable 35,648     66,508  
Other 16,300     (2,316 )
Net cash provided by operating activities 143,259     101,728  
       
CASH FLOWS FROM INVESTING ACTIVITIES:      
Acquisition of property and equipment (11,744 )   (12,871 )
Other investing cash flows     541  
Business acquisitions, net of cash acquired (18,852 )    
Net cash used in investing activities (30,596 )   (12,330 )
       
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from debt 355,200      
Retirement of debt obligations (352,009 )   (125,000 )
Net proceeds from issuance of common stock     118,934  
Deferred financing costs (2,880 )    
Other financing cash flows (11,383 )   (10,341 )
Net cash (used in) provided by financing activities (11,072 )   (16,407 )
NET INCREASE IN CASH AND CASH EQUIVALENTS 101,591     72,991  
Cash and cash equivalents - beginning of the period 99,265     67,056  
CASH AND CASH EQUIVALENTS - END OF PERIOD $ 200,856     $ 140,047  



Schedule 4


OPTION CARE HEALTH, INC. 
QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES
(IN THOUSANDS)
(UNAUDITED)

       
       
  Three Months Ended
September 30,
  Nine Months Ended
September 30,
  2021   2020   2021   2020
Consolidated net income (loss) $ 35,476     $ 1,663     $ 64,431     $ (25,915 )
Interest expense, net 16,000     24,583     52,717     84,102  
Income tax expense 3,087     756     5,096     2,267  
Depreciation and amortization expense 17,115     18,241     52,820     60,054  
Consolidated EBITDA 71,678     45,243     175,064     120,508  
               
EBITDA adjustments              
Accounting principle changes and non-cash charges              
Stock-based incentive compensation 2,516     1,170     6,246     2,588  
Loss on extinguishment of debt     8,349     12,403     8,349  
Restructuring, acquisition, integration and other 3,808     4,461     9,342     22,580  
Consolidated adjusted EBITDA $ 78,002     $ 59,223     $ 203,055     $ 154,025  

 


Primary Logo

Source: Option Care Health, Inc.